{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:27:48Z","timestamp":1765232868166},"reference-count":40,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pyruvate carboxylase (PC) deficiency is a rare autosomal recessive disease and provides clinics in three essential phenotypes. Type B PC deficiency is characterized by lactic acidosis and hyperammonemia. We report a Turkish patient who was diagnosed with type B PC deficiency. Despite the application of anaplerotic treatment with biotin, citrate and arginine-aspartate, continuous veno-venous hemodialysis (CVVHD) treatments were applied due to the failure to keep hyperammonemia and lactic acidosis under control. Ammonia values increasing to 860 \u03bcmol\/L were observed. A homozygous novel variant was detected in PC gene analyses containing a 12-base pair deletion on exon 8. Although the mutation found was not reported previously, it was accepted as a pathogenic variant due to its presence in a functional region of the protein. In type B PC deficiency, although a high level of ammonia is expected, it rarely exceeds 200 \u03bcmol\/L. As far as we know, the present case has the highest ammonia values in the literature. This paper has been shared to highlight to keep PC deficiency in mind regarding the differential diagnosis of hyperammonemia, particularly in the presence of lactic acidosis, and to serve as a model for the use of different modalities in the management process of PC deficiency.<\/jats:p>","DOI":"10.1515\/jpem-2019-0307","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T09:00:55Z","timestamp":1583571655000},"page":"569-574","source":"Crossref","is-referenced-by-count":5,"title":["Challenges in the management of an ignored cause of hyperammonemic encephalopathy: pyruvate carboxylase deficiency"],"prefix":"10.1515","volume":"33","author":[{"given":"Melis","family":"Demir K\u00f6se","sequence":"first","affiliation":[{"name":"Izmir Katip \u00c7elebi University School of Medicine, Department of Pediatrics, Division of Inborn Errors of Metabolism, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruya","family":"Colak","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Neonatology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi","family":"Yangin Ergon","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Neonatology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferit","family":"Kulali","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Neonatology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Neonatology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senem","family":"Alkan","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Neonatology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Atilgan","sequence":"additional","affiliation":[{"name":"Pamukkale University Medical Faculty, Neonatology Department, Denizli, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Aslan","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Nephrology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Brown","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford Medical Genetics Laboratories, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry","family":"Brown","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford Medical Genetics Laboratories, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkin","family":"Serdaro\u011flu","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Nephrology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebnem","family":"\u00c7alkavur","sequence":"additional","affiliation":[{"name":"Beh\u00e7et Uz Children Training & Research Hospital, Neonatology Department, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref111","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1469-8749.1981.tb02026.x","article-title":"A patient with pyruvate carboxylase deficiency in the liver: treatment with aspartic acid and thiamine","volume":"23","year":"1981","journal-title":"Dev Med Child Neurol"},{"key":"ref41","first-page":"1","article-title":"Novel mutations in the PC Gene in patients with Type B pyruvate carboxylase deficiency","volume":"9","year":"2013","journal-title":"JIMD Rep"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainresrev.2007.06.026","article-title":"Hyperammonemia-induced toxicity for the developing central nervous system","volume":"56","year":"2007","journal-title":"Brain Res Rev"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-016-3423-4","article-title":"Neonatal extracorporeal renal replacement therapy-a routine renal support modality?","volume":"31","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00647285","article-title":"Inhibitory effect of intravenous lysine infusion on urea cycle metabolism","volume":"146","year":"1987","journal-title":"Eur J Pediatr"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj2390089","article-title":"Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase","volume":"239","year":"1986","journal-title":"Biochem J"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jnr.24111","article-title":"Triheptanoin for the treatment of brain energy deficit: a 14-year experience","volume":"95","year":"2017","journal-title":"J Neurosci Res"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<331::AID-AJMG10>3.0.CO;2-K","article-title":"Treatment of pyruvate carboxylase deficiency with high doses of citrate and aspartate","volume":"87","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.20709","article-title":"Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects","volume":"59","year":"2006","journal-title":"Ann Neurol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"Pc17","DOI":"10.1016\/S0021-9258(18)69442-6","article-title":"Formation of oxaloacetate from pyruvate and carbon dioxide","volume":"235","year":"1960","journal-title":"J Biol Chem"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2013.04.009","article-title":"Clinical and biochemical aspects of primary and secondary hyperammonemic disorders","volume":"536","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/B978-0-444-59565-2.00034-4","article-title":"Disorders of pyruvate metabolism","volume":"113","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"ref81","first-page":"283","article-title":"The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency","volume":"36","year":"1984","journal-title":"Am J Hum Genet"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2013.04.009","article-title":"Clinical and biochemical aspects of primary and secondary hyperammonemic disorders","volume":"536","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<331::AID-AJMG10>3.0.CO;2-K","article-title":"Treatment of pyruvate carboxylase deficiency with high doses of citrate and aspartate","volume":"87","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/B978-0-444-59565-2.00034-4","article-title":"Disorders of pyruvate metabolism","volume":"113","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2010.05.004","article-title":"Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis","volume":"101","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0009-9120(94)00059-5","article-title":"Prolonged survival in pyruvate carboxylase deficiency: lack of correlation with enzyme activity in cultured fibroblasts","volume":"28","year":"1995","journal-title":"Clin Biochem"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00647285","article-title":"Inhibitory effect of intravenous lysine infusion on urea cycle metabolism","volume":"146","year":"1987","journal-title":"Eur J Pediatr"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.20709","article-title":"Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects","volume":"59","year":"2006","journal-title":"Ann Neurol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00431-013-2166-5","article-title":"Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin","volume":"173","year":"2014","journal-title":"Eur J Pediatr"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1523\/JNEUROSCI.23-13-05928.2003","article-title":"Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy","volume":"23","year":"2003","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"Pc17","DOI":"10.1016\/S0021-9258(18)69442-6","article-title":"Formation of oxaloacetate from pyruvate and carbon dioxide","volume":"235","year":"1960","journal-title":"J Biol Chem"},{"key":"ref281","first-page":"283","article-title":"The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency","volume":"36","year":"1984","journal-title":"Am J Hum Genet"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/cc1518","article-title":"Bench-to-bedside review: lactate and the kidney","volume":"6","year":"2002","journal-title":"Crit Care"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0009-9120(94)00059-5","article-title":"Prolonged survival in pyruvate carboxylase deficiency: lack of correlation with enzyme activity in cultured fibroblasts","volume":"28","year":"1995","journal-title":"Clin Biochem"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1469-8749.1981.tb02026.x","article-title":"A patient with pyruvate carboxylase deficiency in the liver: treatment with aspartic acid and thiamine","volume":"23","year":"1981","journal-title":"Dev Med Child Neurol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2014.09.002","article-title":"Ammonia metabolism and hyperammonemic disorders","volume":"67","year":"2014","journal-title":"Adv Clin Chem"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000132035","article-title":"Congenital lactic acidosis associated with pyruvate carboxylase deficiency. Repository identification No. GM6056","volume":"38","year":"1984","journal-title":"Cytogenet Cell Genet"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00431-013-2166-5","article-title":"Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin","volume":"173","year":"2014","journal-title":"Eur J Pediatr"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj2390089","article-title":"Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase","volume":"239","year":"1986","journal-title":"Biochem J"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1523\/JNEUROSCI.23-13-05928.2003","article-title":"Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy","volume":"23","year":"2003","journal-title":"J Neurosci"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainresrev.2007.06.026","article-title":"Hyperammonemia-induced toxicity for the developing central nervous system","volume":"56","year":"2007","journal-title":"Brain Res Rev"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/cc1518","article-title":"Bench-to-bedside review: lactate and the kidney","volume":"6","year":"2002","journal-title":"Crit Care"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-016-3423-4","article-title":"Neonatal extracorporeal renal replacement therapy-a routine renal support modality?","volume":"31","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2014.09.002","article-title":"Ammonia metabolism and hyperammonemic disorders","volume":"67","year":"2014","journal-title":"Adv Clin Chem"},{"key":"ref241","first-page":"1","article-title":"Novel mutations in the PC Gene in patients with Type B pyruvate carboxylase deficiency","volume":"9","year":"2013","journal-title":"JIMD Rep"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000132035","article-title":"Congenital lactic acidosis associated with pyruvate carboxylase deficiency. Repository identification No. GM6056","volume":"38","year":"1984","journal-title":"Cytogenet Cell Genet"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2010.05.004","article-title":"Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis","volume":"101","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jnr.24111","article-title":"Triheptanoin for the treatment of brain energy deficit: a 14-year experience","volume":"95","year":"2017","journal-title":"J Neurosci Res"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jpem\/33\/4\/article-p569.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0307\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T19:55:48Z","timestamp":1722542148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0307\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":40,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2019-0307","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"type":"electronic","value":"2191-0251"},{"type":"print","value":"0334-018X"}],"subject":[],"published":{"date-parts":[[2020,4,28]]}}}